Sonoma Pharmaceuticals, Inc. (SNOA) financial statements (2022 and earlier)

Company profile

Business Address 645 MOLLY LANE, SUITE 150
WOODSTOCK, GA 30189
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,5294,2203,6913,68910,06617,4617,469
Cash and cash equivalents8,5294,2203,6913,68910,06617,4617,469
Receivables2,8542,8064,0623,4811,5372,1082,274
Inventory, net of allowances, customer advances and progress billings2,8792,5302,1923,4092,8652,2211,640
Inventory2,8792,5302,1923,4092,8652,2211,640
Prepaid expense 3,2182,2561,6161,2776161,127
Other undisclosed current assets3,437209182301509237378
Total current assets:17,69912,98312,38312,49616,25422,64312,888
Noncurrent Assets
Operating lease, right-of-use asset623769963
Property, plant and equipment2993603657271,1361,239850
Other noncurrent assets75112641224948065
Other undisclosed noncurrent assets6517637861,1031,3221,497 
Total noncurrent assets:1,6482,0042,1781,9522,9522,816915
TOTAL ASSETS:19,34714,98714,56114,44819,20625,45913,803
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,5832,9233,8602,7562,6782,5702,863
Accounts payable1,5831,7692,0861,2551,2721,2551,337
Accrued liabilities 367696544589621833
Employee-related liabilities 7871,078957817681693
Taxes payable     13 
Deferred revenue100267228
Debt587596481463377197114
Deferred revenue and credits 176574
Other liabilities   270   
Other undisclosed current liabilities1,605292296102206345 
Total current liabilities:3,8754,0784,8653,5913,2613,2883,551
Noncurrent Liabilities
Long-term debt and lease obligation3621,83974612176213 
Long-term debt, excluding current maturities 1,310 123245 
Capital lease obligations 144168 
Operating lease, liability362529746
Liabilities, other than long-term debt190229245  527112
Deferred revenue and credits 527112
Deferred revenue190229245
Other undisclosed noncurrent liabilities3,7513,478 356443  
Total noncurrent liabilities:4,3035,546991368619740112
Total liabilities:8,1789,6245,8563,9593,8804,0283,663
Stockholders' equity
Stockholders' equity attributable to parent11,1695,3638,70510,48915,32621,43110,140
Common stock3222112
Additional paid in capital197,156189,217186,559184,074176,740168,709166,367
Accumulated other comprehensive loss(4,571)(4,579)(5,610)(4,349)(3,975)(4,178)(3,854)
Accumulated deficit(181,419)(179,277)(172,246)(169,238)(157,440)(143,101)(152,375)
Total stockholders' equity:11,1695,3638,70510,48915,32621,43110,140
TOTAL LIABILITIES AND EQUITY:19,34714,98714,56114,44819,20625,45913,803

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Revenues14,60218,62918,93618,97016,65812,82515,084
Revenue, net 12,82515,084
Cost of revenue(10,965)(12,070)(10,603)(10,090)(9,348)(7,157)(7,874)
Cost of goods and services sold(10,965)(12,070)(10,603)(231)(198)(7,157)(7,874)
Gross profit:3,6376,5598,3338,8807,3105,6687,210
Operating expenses(5,998)(10,008)(15,004)(20,138)(21,499)(18,642)(17,362)
Operating loss:(2,361)(3,449)(6,671)(11,258)(14,189)(12,974)(10,152)
Nonoperating income (expense)133165019025822(18)
Investment income, nonoperating 1650190258222
Other nonoperating expense      (20)
Interest and debt expense (12)(16)(33)(40)(3)(3)
Loss from continuing operations before equity method investments, income taxes:(2,228)(3,445)(6,637)(11,101)(13,971)(12,955)(10,173)
Other undisclosed income (loss) from continuing operations before income taxes(457)(457)3,812(239)(357)18 
Loss from continuing operations before income taxes:(2,685)(3,902)(2,825)(11,340)(14,328)(12,937)(10,173)
Income tax expense (benefit)(5)(713)(121)(458) 4,268 
Other undisclosed loss from continuing operations(23)      
Loss from continuing operations:(2,713)(4,615)(2,946)(11,798)(14,328)(8,669)(10,173)
Income from discontinued operations 665   17,943 
Other undisclosed income before gain (loss) on sale of properties665      
Net income (loss):(2,048)(3,950)(2,946)(11,798)(14,328)9,274(10,173)
Other undisclosed net income (loss) attributable to parent(2,472)     11
Net income (loss) available to common stockholders, diluted:(4,520)(3,950)(2,946)(11,798)(14,328)9,274(10,162)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Net income (loss):(2,048)(3,950)(2,946)(11,798)(14,328)9,274(10,173)
Other comprehensive income (loss)(2,134)(2,919)(4,207)(12,172)(14,125)8,950(10,509)
Other undisclosed comprehensive loss(2,919)      
Comprehensive income (loss):(7,101)(6,869)(7,153)(23,970)(28,453)18,224(20,682)
Other undisclosed comprehensive loss, net of tax, attributable to parent(2,640)      
Comprehensive income (loss), net of tax, attributable to parent:(9,741)(6,869)(7,153)(23,970)(28,453)18,224(20,682)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: